JPY5,328.00
0.26% yesterday
Tokyo, Aug 01, 08:02 am CET
ISIN
JP3301100008
Symbol
4967

Kobayashi Pharmaceutical Target price 2025 - Analyst rating & recommendation

Kobayashi Pharmaceutical Classifications & Recommendation:

Buy
42%
Hold
58%

Kobayashi Pharmaceutical Price Target

Target Price JPY5,528.40
Price JPY5,333.00
Potential
Number of Estimates 9
9 Analysts have issued a price target Kobayashi Pharmaceutical 2026 . The average Kobayashi Pharmaceutical target price is JPY5,528.40. This is higher than the current stock price. The highest price target is
JPY7,035.00 31.91%
register free of charge
, the lowest is
JPY5,050.00 5.31%
register free of charge
.
A rating was issued by 12 analysts: 5 Analysts recommend Kobayashi Pharmaceutical to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Kobayashi Pharmaceutical stock has an average upside potential 2026 of . Most analysts recommend the Kobayashi Pharmaceutical stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion JPY 165.60 172.17
4.53% 3.97%
EBITDA Margin 17.93% 15.18%
7.33% 15.36%
Net Margin 6.08% 7.82%
48.15% 28.64%

9 Analysts have issued a sales forecast Kobayashi Pharmaceutical 2025 . The average Kobayashi Pharmaceutical sales estimate is

JPY172b
Unlock
. This is
6.46% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY185b 14.46%
Unlock
, the lowest is
JPY164b 1.20%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 JPY166b 4.53%
2025
JPY172b 3.97%
Unlock
2026
JPY181b 5.05%
Unlock
2027
JPY188b 4.18%
Unlock

9 Kobayashi Pharmaceutical Analysts have issued a net profit forecast 2025. The average Kobayashi Pharmaceutical net profit estimate is

JPY13.5b
Unlock
. This is
25.72% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY19.8b 85.21%
Unlock
, the lowest is
JPY10.5b 2.16%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 JPY10.1b 50.50%
2025
JPY13.5b 33.81%
Unlock
2026
JPY15.5b 14.92%
Unlock
2027
JPY17.2b 11.12%
Unlock

Net Margin

2024 6.08% 48.15%
2025
7.82% 28.64%
Unlock
2026
8.56% 9.46%
Unlock
2027
9.13% 6.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share JPY 135.42 181.21
49.50% 33.81%
P/E 29.33
EV/Sales 1.90

9 Analysts have issued a Kobayashi Pharmaceutical forecast for earnings per share. The average Kobayashi Pharmaceutical EPS is

JPY181.21
Unlock
. This is
25.72% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
JPY266.95 85.20%
Unlock
, the lowest is
JPY141.02 2.16%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 JPY135.42 49.50%
2025
JPY181.21 33.81%
Unlock
2026
JPY208.24 14.92%
Unlock
2027
JPY231.39 11.12%
Unlock

P/E ratio

Current 36.87 15.93%
2025
29.33 20.44%
Unlock
2026
25.52 12.99%
Unlock
2027
22.97 9.99%
Unlock

Based on analysts' sales estimates for 2025, the Kobayashi Pharmaceutical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.02 13.68%
2025
1.90 5.99%
Unlock
2026
1.81 4.81%
Unlock
2027
1.74 4.02%
Unlock

P/S ratio

Current 2.43 9.42%
2025
2.29 6.07%
Unlock
2026
2.18 4.81%
Unlock
2027
2.09 4.01%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today